Drugs for Gastrointestinal Diseases Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Drugs for Gastrointestinal Diseases. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Drugs for Gastrointestinal Diseases Indian Medical PG Question 1: Which of the following statements regarding peptic ulcers are correct?
1. Duodenal ulcers are more common as compared to gastric ulcers.
2. Helicobacter pylori and NSAIDs are most common causative agents.
3. Bleeding is the most common complication associated with posterior duodenal ulcer.
- A. 2 and 3 only
- B. 1, 2 and 3
- C. 1 and 2 only (Correct Answer)
- D. 1 and 3 only
Drugs for Gastrointestinal Diseases Explanation: ***1 and 2 only***
- **Duodenal ulcers** are significantly more common than gastric ulcers, with a ratio of about 4:1 [1].
- The two primary causes of peptic ulcers are infection with **_Helicobacter pylori_** and the use of **non-steroidal anti-inflammatory drugs (NSAIDs)** [1].
*2 and 3 only*
- While _**H. pylori**_ and **NSAIDs** are indeed the most common causes, the statement incorrectly assumes that bleeding is the most common complication associated with **posterior duodenal ulcers**, when the most common complication of all peptic ulcers is **hemorrhage** but it is more specifically associated with posterior duodenal ulcers due to proximity to the **gastroduodenal artery**.
- Hence, the second and third statements are individually correct, but the first statement which says duodenal ulcers are more common then gastric ulcers is also correct.
*1, 2 and 3*
- While statements 1 and 2 are correct individually, statement 3, which attributes bleeding as the most common complication specifically to posterior duodenal ulcers, is correct because posterior duodenal ulcers are particularly prone to bleeding due to the proximity of the **gastroduodenal artery** [1].
- Thus, all three statements are individually correct, but the combination chosen is redundant.
*1 and 3 only*
- This option is flawed because it omits statement 2, which correctly identifies **_H. pylori_** and **NSAIDs** as the primary causes of peptic ulcers [1].
- Although posterior duodenal ulcers are associated with bleeding, statement 3 is not complete enough without the inclusion of statement 2.
Drugs for Gastrointestinal Diseases Indian Medical PG Question 2: The drug used in steroid-refractory acute severe ulcerative colitis is:
- A. Steroids
- B. Infliximab
- C. Cyclosporine (Correct Answer)
- D. Sulfasalazine
Drugs for Gastrointestinal Diseases Explanation: ***Cyclosporine***
- **Cyclosporine** is an effective **calcineurin inhibitor** used in cases of **acute severe ulcerative colitis** that are refractory to steroid therapy [1].
- It acts by suppressing the immune system and reducing inflammation in the colon, thereby preventing colectomy [1].
*Sulfasalazine*
- **Sulfasalazine** is an **aminosalicylate** commonly used for mild to moderate ulcerative colitis, particularly for maintaining remission [1].
- It is not considered a primary treatment for **acute severe, steroid-refractory** disease [1].
*Steroids*
- The question explicitly states "steroid-refractory," meaning the patient has already failed **steroid therapy** [1].
- Therefore, using **steroids** again as the primary intervention for this specific clinical scenario would not be appropriate.
*Infliximab*
- **Infliximab**, an **anti-TNF-α agent**, is also used in steroid-refractory acute severe ulcerative colitis [1].
- However, **cyclosporine** has a **more rapid onset of action** which makes it a preferred initial option in severe cases; Infliximab is often considered after cyclosporine failure or in scenarios where cyclosporine is contraindicated.
Drugs for Gastrointestinal Diseases Indian Medical PG Question 3: Which of the following is NOT an H2 receptor antagonist?
- A. Cimetidine
- B. Ranitidine
- C. Famotidine
- D. Esomeprazole (Correct Answer)
Drugs for Gastrointestinal Diseases Explanation: ***Esomeprazole***- **Esomeprazole** is a **proton pump inhibitor (PPI)**, which works by irreversibly blocking the H+/K+-ATPase pump in gastric parietal cells, thereby reducing acid secretion [1].- All other options listed are H2 receptor antagonists, making esomeprazole the correct answer as it is *not* an H2 blocker [1, 2].*Ranitidine*- **Ranitidine** is an **H2 receptor antagonist** that competitively blocks histamine from binding to H2 receptors on parietal cells, leading to decreased gastric acid secretion [2].- It was commonly used for conditions like GERD and peptic ulcers, though its use has been restricted due to contamination concerns.*Famotidine*- **Famotidine** is also an **H2 receptor antagonist** that works similarly to ranitidine by blocking H2 receptors on parietal cells to reduce acid production [2].- It is frequently used for managing conditions associated with excess stomach acid.*Cimetidine*- **Cimetidine** is the **first-generation H2 receptor antagonist** that competitively inhibits histamine binding at H2 receptors on gastric parietal cells [2].- While effective for acid suppression, it has more drug interactions and side effects compared to newer H2 antagonists due to its inhibition of cytochrome P450 enzymes.
Drugs for Gastrointestinal Diseases Indian Medical PG Question 4: In a young, otherwise healthy patient with a newly suspected diagnosis of peptic ulcer disease, what would be the most appropriate course of action in the emergency department?
- A. Immediate referral for endoscopy
- B. Begin combination therapy with an H2 receptor antagonist, proton pump inhibitor, and antacids
- C. Begin symptomatic and therapeutic treatment with a proton pump inhibitor (e.g., omeprazole) (Correct Answer)
- D. Begin empiric treatment of H. pylori with a triple antibiotic regimen after confirmation of infection
Drugs for Gastrointestinal Diseases Explanation: **Begin symptomatic and therapeutic treatment with a proton pump inhibitor (e.g., omeprazole)**
- In a stable patient with suspected peptic ulcer disease, **empiric therapy with a PPI** is the most appropriate initial step in the emergency department for symptom relief and healing [1].
- PPIs effectively reduce **gastric acid secretion**, promoting ulcer healing and alleviating pain, while further diagnostic workup can be planned [1].
*Immediate referral for endoscopy*
- While endoscopy is the gold standard for diagnosing peptic ulcers, it is **not generally an emergency procedure** in a stable, otherwise healthy patient without signs of complications such as bleeding or perforation [2].
- Endoscopy is typically reserved for cases where initial medical management fails, or if there are **alarm features** (e.g., weight loss, dysphagia, GI bleeding).
*Begin combination therapy with an H2 receptor antagonist, proton pump inhibitor, and antacids*
- This combination is **excessive and generally unnecessary** for initial management, as PPIs alone are highly effective.
- **Polypharmacy** increases the risk of side effects and may confuse subsequent diagnostic assessments without offering significant additional benefit in an acute setting.
*Begin empiric treatment of H. pylori with a triple antibiotic regimen after confirmation of infection*
- **Empiric H. pylori treatment** without confirmation of infection is not recommended, as it can lead to unnecessary antibiotic exposure and drug resistance.
- **Confirmation of H. pylori infection** (via breath test, stool antigen, or biopsy) should precede, or ideally follow with specific testing, before initiating antibiotic therapy [1].
Drugs for Gastrointestinal Diseases Indian Medical PG Question 5: Proton pump inhibitors for peptic ulcer disease should be taken:
- A. Before Breakfast (Correct Answer)
- B. After Breakfast
- C. Before Dinner
- D. After Dinner
Drugs for Gastrointestinal Diseases Explanation: ***Before Breakfast***
- Proton pump inhibitors (PPIs) are most effective when taken **30-60 minutes before the first meal of the day**.
- This timing allows the drug to reach peak plasma concentration when the greatest number of **proton pumps** are activated by food intake, maximizing their inhibitory effect on acid secretion.
*After Breakfast*
- Taking PPIs after breakfast significantly reduces their effectiveness because many **proton pumps** would have already been active and subsequently inactivated before the drug can exert its full effect.
- This timing leads to suboptimal acid suppression, potentially hindering the healing of **peptic ulcers**.
*Before Dinner*
- While taking a second daily dose before dinner can be beneficial for some patients with persistent symptoms, it is not the primary or most effective administration time for a **once-daily dose**.
- The main goal is to suppress the **meal-stimulated acid secretion** throughout the day, which is best achieved by the morning dose.
*After Dinner*
- Administering PPIs after dinner is generally ineffective for the same reasons as taking them after breakfast; the **proton pumps** have already been activated and then inactivated, diminishing the drug's impact.
- This timing would lead to inadequate acid control, especially during the day when most acid secretion occurs.
More Drugs for Gastrointestinal Diseases Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
